[Funding alert] Belgium-based Home Sleep Diagnostics Company Sunrise Secures $6M in Funding

The business is going to use the funds to expand its influence even more. Under the direction of CEO Laurent Martinot, Sunrise is developing sleep diagnostics that are user-friendly, accurate, and dependable for patients as well as healthcare providers.

Read also - UK-based Accenture Acquire 6point6

The startup uses an 8-gram sensor that is comfortably positioned on the chin to provide a high-precision tool for sleep diagnosis by concentrating on these jaw movements.

Furthermore, Sunrise assesses "respiratory effort," a parameter that is frequently disregarded in at-home sleep examinations. It makes it possible to differentiate between obstructive and central sleep apnea.

Read also - SUPPLYZ Rebrands as RESONIKS and Secures Investment from Kvanted

It additionally offers novel measurements, such as "respiratory effort burden," which has been connected to hypertension, type II diabetes, and exhaustion. Such thorough understandings open the door to more individualised care and improved health outcomes for those with sleep disorders.

Sunrise also maintains offices in the US and France. It received two FDA approvals in the US and an updated CE certification in Europe under MDR.

About Sunrise

Sunrise goal is to include sleep testing into their daily routines. The answer is straightforward: while a startling proportion of individuals go misdiagnosed, getting enough sleep is essential for good health overall.

Read also - Chasse sur Rhône-based Recyc’ELIT Raises €3.2M in Funding

By utilising patented technology, they are improving sleep diagnostics to make them more user-friendly and accurate for patients as well as healthcare professionals.